Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Polyherbacy Prompts Need For Physician’s Advice

25.07.2003


Two University of Iowa Health Care physicians are calling attention to the issue of polyherbacy, the excessive or inappropriate ingestion of herbs for the treatment or prevention of disease, especially in older patients.


Jose Ness, M.D., UI assistant professor (clinical) of internal medicine, and Nicole Nisly, M.D., associate professor (clinical) of internal medicine and director of the UI Complimentary and Alternative Medicine Clinic



Jose Ness, M.D., UI assistant professor (clinical) of internal medicine, and Nicole Nisly, M.D., associate professor (clinical) of internal medicine and director of the UI Complimentary and Alternative Medicine Clinic, published a letter on polyherbacy in the May issue of the Journal of Gerontology.

The physicians said that oftentimes patients take herbal supplements in conjunction with their regular medicine regimen. However, combining conventional medications with herbal supplements without first talking to your physician can lead to possible adverse interactions with medication or illness.


Prior to taking an herbal supplement, a patient should have established a treatment goal, researched reliable sources for herbal information and consulted with their physician or pharmacist about safety and efficacy of the herbs.

"Patients should always discuss with their primary physician any medication, herbal or conventional, they’re taking," Ness said. "Physicians can then find out about possible side effects and help prevent unexpected complications."

Patients should also talk to their physician or pharmacist about conventional treatment options that are available to ensure the proper and best treatment is given, Nisly said.

"A patient is more likely to begin taking herbal supplements if they do not see desired results from more conventional methods," Nisly said.

Herbal supplements should not be used by children or anyone who is pregnant, lactating or receiving chemotherapy, HIV treatment, transplant medications or anticoagulants, due to increased risk of adverse side effects.

Commonly used herbs include ginseng, ginkgo biloba, garlic, St. Johns Wort, aloe and Echinacea. Sea algae and licorice are commonly found in multi-ingredient supplements.

Possible side effects can include headache, abdominal pain, fatigue and nausea. More serious side effects can include excessive bleeding or interaction with other drugs, resulting in excessive or diminished drug function, Nisly said.

Each herb can come in several forms, each different enough to cause differing side effects. "It is important to remember that just as with other medications, it is possible to experience an allergic reaction to an herbal supplement," Ness said.

While serious herbal complications are not common, Ness noted, caution is a must. The sicker a patient is, the more likely he or she is to experience such adverse reactions.

Ness added that there is a lack of standardization in herbal manufacturing, which is not approved or regulated by the Food and Drug Administration. Some supplements are produced with quality control standards similar to drug production, but some are not. Concerns with misidentified herbs and contaminants need to be kept in mind by both consumers and health care professionals.

Reading bottle labels is a valuable resource for learning about a product. The more information a label provides about dosage, ingredients, company reputation and contact info, the better. Patients should look for single-herb supplements known for safety and efficacy from reliable manufacturers.

Doctors need to be informed about herbal uses, interactions and side effects, so they are best able to counsel patients on safe herbal use.

"Doctors need to remember to listen with an open mind when patients talk about their preferred method of treatment, or the patient might withhold information such as herbal use," Ness said.

Ness and Nisly agree that the most important thing to remember when beginning any medication is to talk honestly and openly with your primary physician, in order to ensure the best care and safest use possible.

Becky Soglin | University of Iowa
Further information:
http://www.uihealthcare.com

More articles from Health and Medicine:

nachricht Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>